ProShares Launches Two New Exchange Traded Funds Based on the NASDAQ … – CNNMoney.com (press release)
By Dr. Matthew Watson
 ETF Database | ProShares Launches Two New Exchange Traded Funds Based on the NASDAQ ... CNNMoney.com (press release) 2 ProShares Ultra Nasdaq Biotechnology (Nasdaq:BIB) aims to provide investment results that correspond to 200% of the daily performance of the NASDAQ ... ProShares Launches First Leveraged and Inverse Biotechnology ETFsMarketWatch (press release) Avoid New Biotech Leveraged ETFsTheStreet.com (subscription) Double Your Biotech Returns! Really!Motley Fool Benzinga -Before It's News -Emii.com all 52 news articles » |
Uncategorized
Comments Off on ProShares Launches Two New Exchange Traded Funds Based on the NASDAQ … – CNNMoney.com (press release) |
April 10th, 2010
This author published 5852 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research